Methamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: Relevance for HIV associated neurocognitive disorders

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Pendyala, Gurudutt ^a   Buescher, James L ^a   Fox, Howard S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYTOKINE; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; NEURON SPECIFIC SODIUM POTASSIUM ATPASE ALPHA 1 ISOFORM 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; EMBRYO; HIV ASSOCIATED DEMENTIA; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; RHESUS MONKEY; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SYNAPTOSOME; UPREGULATION;

ANIMALS; CELL SURVIVAL; COGNITION DISORDERS; CYTOKINES; ENZYME ACTIVATION; HIV INFECTIONS; HUMANS; MACACA MULATTA; METHAMPHETAMINE; NEURONS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SODIUM-POTASSIUM-EXCHANGING ATPASE; SUBSTANCE-RELATED DISORDERS;

HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84861476880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037604     Document Type: Article

References (52)

1. McArthur JC, Steiner J, Sacktor N, Nath A, (2010) Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol 67: 699-714.
2. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, et al. (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
3. Strathdee SA, Stockman JK, (2010) Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep 7: 99-106.
4. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, et al. (2010) Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs 42: 11-18.
5. Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD, (2009) Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care 21: 575-582.
6. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, et al. (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10: 1-14.
7. Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE, (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64: 133-145.
8. Sharer LR, (1992) Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 51: 3-11.
9. Cadet JL, Krasnova IN, (2007) Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 12: 181-204.
10. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, et al. (2010) Meth/amphetamine use and associated HIV: Implications for global policy and public health. Int J Drug Policy 21: 347-358.
11. Cadet JL, Krasnova IN, (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88: 101-119.
12. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, et al. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42: 963-972.
13. Marcondes MC, Flynn C, Watry DD, Zandonatti M, Fox HS, (2010) Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am J Pathol 177: 355-361.
14. Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, Fox HS, (2005) Susceptibility of Chinese rhesus monkeys to SIV infection. Aids 19: 1704-1706.
15. Watry D, Lane TE, Streb M, Fox HS, (1995) Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. The American Journal of Pathology 146: 914-923.
16. Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, et al. (1981) A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res 226: 107-118.
17. Pendyala G, Trauger SA, Siuzdak G, Fox HS, (2010) Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J Proteome Res 9: 352-358.
18. Pendyala G, Trauger SA, Siuzdak G, Fox HS, (2011) Short communication: quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidity. AIDS Res Hum Retroviruses 27: 179-182.
19. Wiederin JL, Donahoe RM, Anderson JR, Yu F, Fox HS, et al. (2010) Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques. J Proteome Res 9: 4721-4731.
20. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, et al. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6: 1638-1655.
21. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS, (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3: e2906.
22. Gjerde H, Hasvold I, Pettersen G, Christophersen AS, (1993) Determination of amphetamine and methamphetamine in blood by derivatization with perfluorooctanoyl chloride and gas chromatography/mass spectrometry. J Anal Toxicol 17: 65-68.
23. Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, et al. (2001) Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci Int 116: 163-169.
24. Klette KL, Kettle AR, Jamerson MH, (2006) Prevalence of use study for amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxy-amphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA), and 3,4-methylenedioxy-ethylamphetamine (MDEA) in military entrance processing stations (MEPS) specimens. J Anal Toxicol 30: 319-322.
25. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, et al. (2006) Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther 10: 257-269.
26. Melega WP, Cho AK, Harvey D, Lacan G, (2007) Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61: 216-220.
27. Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, et al. (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49: 121-132.
28. Takayasu T, Ohshima T, Nishigami J, Kondo T, Nagano T, (1995) Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases. J Clin Forensic Med 2: 25-33.
29. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
30. Nath A, Geiger J, (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 54: 19-33.
31. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB, (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83: 7089-7093.
32. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, et al. (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44: 474-481.
33. Tornatore C, Chandra R, Berger JR, Major EO, (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481-487.
34. Burudi EM, Marcondes MC, Watry DD, Zandonatti M, Taffe MA, et al. (2002) Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol 76: 12233-12241.
35. Orandle MS, MacLean AG, Sasseville VG, Alvarez X, Lackner AA, (2002) Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J Virol 76: 5797-5802.
36. Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, et al. (2011) Editorial neuroAIDS review. Aids 25: 123-141.
37. Desfrere L, Karlsson M, Hiyoshi H, Malmersjo S, Nanou E, et al. (2009) Na,K-ATPase signal transduction triggers CREB activation and dendritic growth. Proc Natl Acad Sci U S A 106: 2212-2217.
38. Geering K, (2008) Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens 17: 526-532.
39. de Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, et al. (2004) Mutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43: 169-175.
40. Clapcote SJ, Duffy S, Xie G, Kirshenbaum G, Bechard AR, et al. (2009) Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc Natl Acad Sci U S A 106: 14085-14090.
41. DeAndrade MP, Yokoi F, van Groen T, Lingrel JB, Li Y, (2011) Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 216: 659-665.
42. Gelman BB, Nguyen TP, (2009) Synaptic Proteins Linked to HIV-1 Infection and Immunoproteasome Induction: Proteomic Analysis of Human Synaptosomes. J Neuroimmune Pharmacol.
43. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675.
44. Segal RA, Greenberg ME, (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19: 463-489.
45. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME, (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
46. Creedon DJ, Johnson EM, Lawrence JC, (1996) Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 271: 20713-20718.
47. Murray B, Alessandrini A, Cole AJ, Yee AG, Furshpan EJ, (1998) Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc Natl Acad Sci U S A 95: 11975-11980.
48. Runden E, Seglen PO, Haug FM, Ottersen OP, Wieloch T, et al. (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 18: 7296-7305.
49. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, et al. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275: 12200-12206.
50. Chang L, Ernst T, Speck O, Grob CS, (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162: 361-369.
51. Potula R, Hawkins BJ, Cenna JM, Fan S, Dykstra H, et al. (2010) Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J Immunol 185: 2867-2876.
52. Abdul Muneer PM, Alikunju S, Szlachetka AM, Haorah J, (2011) Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine. PLoS ONE 6: e19258.